Apollo Hospitals reported an over 20 percent dip in the bottomline this quarter. In an interview Suneeta Reddy, MD of the company discussed the earnings fine print.

The impact of goods and services tax (GST) on stems was around Rs 10 crore we have also lost another Rs 5 crore because of GST said Reddy, adding that the impact of GST was also felt in the pharmacy, which impacted growth.

The company saw revenue growth of 13 percent this quarter on a year on year (YoY) basis. There was a loss of Rs 30 crore due to Navi Mumbai operations in H1, she added.

In terms of average occupancy, she said occupancies have moved up and are averaging at around 68 percent and in mature hospitals, it is around 71 percent.

Chennai cluster performance has recovered and there is a revenue growth of about 4 percent, she further mentioned.

Apollo Hospitals has 2,742 pharmacies and they have added 191 pharmacies this quarter, which led to some dilution of margins, said Reddy. The pharmacies opened in 2010 saw 5 percent revenue growth and 7.3 percent EBITDA margin, she added.

Apollo Health and Lifestyle has recorded a revenue of Rs 148 crore, she said. – Money Control


A New Cancer Treatment

 

Digital version